Childhood Cancers

Retevmo was approved for childhood metastatic medullary thyroid, thyroid and solid tumors with RET mutations or gene fusions.

Curing childhood cancer, any kind, is no place to be divided.

Ojemda treatment for certain patients with pediatric low-grade glioma is “well-tolerated” and may be safer than traditional options, an expert told CURE®.

The FDA has granted accelerated approval to Ojemda for patients 6 months and older with relapsed or refractory pediatric low-grade glioma with a BRAF fusion or rearrangement, or BRAF V600 mutation.

Lutathera was approved for patients 12 or older with SSTR-positive gastroenteropancreatic neuroendocrine tumors, the FDA announced.

Cancer comes with an awful storm, but the prisms of light can make it a little less worse.

Besponsa provides another — and potentially more effective — option outside of traditional chemotherapy for pediatric patients with relapsed or refractory B-ALL.

Musical play engages children with cancer, which relieves stress for them and their parents/caregivers, an expert said.

The investigational drug LSTA1 is being explored for the treatment of osteosarcoma, which starts in the bones and accounts for 2% of childhood cancers.

Survivors of rhabdomyosarcoma may be at higher risk for poorer psychological outcomes, that radiation therapy and smoking may worsen.

The Food and Drug Administration approved Besponsa for pediatric patients aged 1 and older with relapsed or refractory CD22-positive, B-cell precursor ALL.

“Waiting” described the waiting room at Children’s Hospital to get my chemotherapy. “My Days” was a remembrance of the year I was diagnosed with leukemia.

A young girl once fought as hard as she could though cancer.

From International Childhood Cancer Day to an Ivory Coast soccer player making a victorious comeback after testicular cancer, here’s what is happening in the oncology space this week.

New guidelines provide a framework for pediatric neuroblastoma treatment — as well as conversations families should have with their oncology teams.

From Broadway actor Jeff Gorti opening up about his childhood cancer experience to Brian Barczyk of The Reptarium dying, here’s what’s happening in the oncology space this week.

Recent research determined that two specific biomarkers may help predict and protect survivors of childhood cancer from heart risks, such as cardiomyopathy.

Children with cancer tended to feel less anxiety after undergoing four sessions of creative art therapy, recent research showed.

The Food and Drug Administration approved Iwilfin for high-risk neuroblastoma in adult and pediatric patients who previously had at least a partial response to a multiagent, modality therapy.

As Shannen Doherty revealed her cancer diagnoses and upcoming podcast and a woman with breast cancer completed her bucket list, here is what’s happening in the oncology space this week.

From Dick Vitale to Make-A-Wish’s Miles Scott reveal that they are cancer free, here is what’s happening in the oncology space this week.

This expanded indication broadens the use of Rozlytrek for solid tumors to include children one month old, with the original approval in 2019 only including children one year and older.

Laura Shinn and Jenna Cavalero, both former childhood patients of the Children’s Hospital of New Orleans, reflect on how their cancer journeys inform their work with patients today.

Ashton’s story starts with her. Our beautiful, big-hearted, kind girl.

The FDA approved Bosulif for children aged 1 and older with newly diagnosed or resistant/intolerant chronic myelogenous leukemia.

Using inter-arterial chemotherapy compared to intravenous chemotherapy may significantly improve globe salvage rates in children with advanced unilateral retinoblastoma.

As Jill Biden helps to heighten Medicare for cancer patients, 15-year old swimmer raises money for Swim Across America and Carlos Carrasco furthers his program, “Cookie’s Kids,” this is what is happening in the oncology space this week.

Being treated for Hodgkin lymphoma during childhood can result in fertility declines, a recent study shows.

A chemotherapy shortage is resulting in altered treatment plans for many patients with cancer. CURE® spoke with experts about what that means for patients — and what they can do about it.

Factors including race, insurance and treatment history have been associated with increased cardiovascular disease, risk factors and mortality among cancer survivors, including those with a history of pediatric cancer, according to recent research.